Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Niuhuang Shedan Chuanbei Ye is a Traditional Chinese Medicine (TCM) oral liquid formulation developed and manufactured by Shandong Kongfu Pharmaceutical. It is composed of key active ingredients including artificial bezoar (Calculus Bovis), snake gallbladder, and Fritillaria cirrhosa. The medication is primarily indicated for clearing lung-heat, resolving phlegm, and suppressing cough. It is commonly used to treat respiratory conditions characterized by cough with yellow, thick phlegm, chest congestion, and sore throat. The pharmacological effects are attributed to the anti-inflammatory, expectorant, and antitussive properties of its constituent herbal extracts, which work synergistically to reduce respiratory tract irritation and facilitate the expulsion of mucus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on niuhuang shedan chuanbei ye.